Michael Thomas Heffernan - 28 Jun 2023 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
Director
Signature
/s/ Christopher Galletta, attorney-in-fact
Issuer symbol
TRVI
Transactions as of
28 Jun 2023
Transactions value $
$0
Form type
4
Filing time
30 Jun 2023, 16:00:36 UTC
Previous filing
26 Jun 2023
Next filing
02 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI Nonstatutory Stock Option (right to buy) Award $0 +30K $0.00 30K 28 Jun 2023 Common Stock 30K $2.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 28, 2023. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.